Patients with psoriasis have significantly more difficulty sleeping, particularly in new environments, than matched ...

A multicenter study finds no difference in outcomes between frail and nonfrail elderly patients treated with tildrakizumab ...

Psoriasis is a long-term disease that affects the immune system. It makes skin cells grow too fast. Instead of new cells ...

Health experts reveal the impact of the inflammatory skin condition on joints, and highlight symptoms and management tips ...

Psoriasis is a chronic skin disorder causing red, scaly plaques, affecting various body parts, with varying severity levels.

There’s no such thing as one-size-fits-all when it comes to a skincare routine – particularly those of us with skin ...

Switching to a different class of biologic improves psoriasis outcomes but may raise infection risk in some cases, a ...

APREMILAST demonstrated sustained efficacy and a consistent safety profile over 52 weeks in paediatric patients with moderate ...

Patients with severe psoriasis who were treated with TNFi long-term had a lower risk of developing PsA than those treated with phototherapy.

Large cohort study finds TNF inhibitors linked to lower cancer risk in psoriasis, supporting long-term safety of biologic ...

Psoriasis is a chronic disease caused by an overactive immune system associated with inflammation throughout the body. Symptoms tend to resolve and reoccur throughout a person’s life. It is estimated ...